Nikolaos A. Diakos, MD, PhD

Nikolaos A. Diakos, MD, PhD, is an interventional cardiologist and specialist in heart failure who is pioneering new treatments and devices. He is recognized for his substantial clinical and translational research accomplishments in the areas of heart failure and mechanical cardiac support.

Show full bio

Dr. Diakos has authored many papers in high-impact, peer-reviewed journals such as the Journal of the American College of Cardiology and the Journal of Heart and Lung Transplantation. He has also won almost a dozen awards for his research, including an award from the International Society for Heart and Lung Transplantation, a Research Merit Scholarship from the Acute Cardiac Unloading and Recovery Working Group (A-Cure), and numerous awards from the Hellenic Cardiological Society.

He is certified by the Educational Commission for Foreign Medical Graduates, the American Board of Internal Medicine (Internal Medicine, Cardiovascular Disease), and the National Board of Echocardiography.

He sees patients at The Texas Heart Institute Medical Group at 6624 Fannin Suite 2780, Houston, Texas 77030. For appointments, call (713) 790-9401.

 

 

See Publications

Texas Heart Institute Positions

Interests

  • Interventional Cardiology
  • Heart Failure
  • Mechanical Circulatory Support
  • Heart Transplantation

Education

  • Postgraduate:

    University of Athens School of Medicine, Athens, Greece

  • Medical School:

    University of Athens School of Medicine, Athens, Greece

  • Residency:

    University of Utah, Salt Lake City, Utah

  • Fellowships:

    Research: Utah Cardiac Recovery Program, University of Utah Molecular Medicine Program, Eccles Institute of Human Genetics, Salt Lake City, Utah
    Cardiovascular Disease: Tufts Medical Center, Boston, Massachusetts
    Advance Heart Failure/Transplant: New York Presbyterian Hospital-Columbia University, New York City, New York
    Interventional Cardiology: Montefiore Medical Center, Bronx, New York

Academic & Clinical Affiliations

Certifications

  • American Board of Internal Medicine, Cardiovascular Disease
  • American Board of Internal Medicine, Internal Medicine

Honors, Awards and Memberships

Publications

4862227 49D7YU3P 1 alternatives-to-animal-experimentation 10 date desc Diakos 46316 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22FK4NJLWC%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Diakos%22%2C%22parsedDate%22%3A%222023-05-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BDiakos%26lt%3B%5C%2Fstrong%26gt%3B%2C%20N.%20A.%20%282023%29.%20Management%20of%20cardiogenic%20shock%3A%20Present%20and%20future.%20%26lt%3Bi%26gt%3BTex%20Heart%20Inst%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B50%26lt%3B%5C%2Fi%26gt%3B%2C%20e238119.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-23-8119%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-23-8119%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Management%20of%20cardiogenic%20shock%3A%20Present%20and%20future%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikolaos%20A.%22%2C%22lastName%22%3A%22Diakos%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222023-05-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.14503%5C%2FTHIJ-23-8119%22%2C%22ISSN%22%3A%221526-6702%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2249D7YU3P%22%2C%22Q46ISS7S%22%5D%2C%22dateModified%22%3A%222023-07-21T19%3A07%3A56Z%22%7D%7D%2C%7B%22key%22%3A%22EYEETDRK%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Diakos%20et%20al.%22%2C%22parsedDate%22%3A%222021-10-19%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BDiakos%26lt%3B%5C%2Fstrong%26gt%3B%2C%20N.%20A.%2C%20Taleb%2C%20I.%2C%20Kyriakopoulos%2C%20C.%20P.%20et%20al.%20%282021%29.%20Circulating%20and%20Myocardial%20Cytokines%20Predict%20Cardiac%20Structural%20and%20Functional%20Improvement%20in%20Patients%20With%20Heart%20Failure%20Undergoing%20Mechanical%20Circulatory%20Support.%20%26lt%3Bi%26gt%3BJ%20Am%20Heart%20Assoc%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B10%26lt%3B%5C%2Fi%26gt%3B%2C%20e020238.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FJAHA.120.020238%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FJAHA.120.020238%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Circulating%20and%20Myocardial%20Cytokines%20Predict%20Cardiac%20Structural%20and%20Functional%20Improvement%20in%20Patients%20With%20Heart%20Failure%20Undergoing%20Mechanical%20Circulatory%20Support%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikolaos%20A.%22%2C%22lastName%22%3A%22Diakos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Iosif%22%2C%22lastName%22%3A%22Taleb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christos%20P.%22%2C%22lastName%22%3A%22Kyriakopoulos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%20S.%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hadi%22%2C%22lastName%22%3A%22Javan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tyler%20J.%22%2C%22lastName%22%3A%22Richins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20Y.%22%2C%22lastName%22%3A%22Yin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chi-Gang%22%2C%22lastName%22%3A%22Yen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Dranow%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20J.%22%2C%22lastName%22%3A%22Bonios%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rami%22%2C%22lastName%22%3A%22Alharethi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antigone%20G.%22%2C%22lastName%22%3A%22Koliopoulou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariam%22%2C%22lastName%22%3A%22Taleb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20C.%22%2C%22lastName%22%3A%22Fang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Craig%20H.%22%2C%22lastName%22%3A%22Selzman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Konstantinos%22%2C%22lastName%22%3A%22Stellos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stavros%20G.%22%2C%22lastName%22%3A%22Drakos%22%7D%5D%2C%22abstractNote%22%3A%22Background%20Recent%20prospective%20multicenter%20data%20from%20patients%20with%20advanced%20heart%20failure%20demonstrated%20that%20left%20ventricular%20assist%20device%20%28LVAD%29%20support%20combined%20with%20standard%20heart%20failure%20medications%2C%20induced%20significant%20cardiac%20structural%20and%20functional%20improvement%2C%20leading%20to%20high%20rates%20of%20LVAD%20weaning%20in%20selected%20patients.%20We%20investigated%20whether%20preintervention%20myocardial%20and%20systemic%20inflammatory%20burden%20could%20help%20identify%20the%20subset%20of%20patients%20with%20advanced%20heart%20failure%20prone%20to%20LVAD-mediated%20cardiac%20improvement%20to%20guide%20patient%20selection%2C%20treatment%2C%20and%20monitoring.%20Methods%20and%20Results%20Ninety-three%20patients%20requiring%20durable%20LVAD%20were%20prospectively%20enrolled.%20Myocardial%20tissue%20and%20blood%20were%20acquired%20during%20LVAD%20implantation%2C%20for%20measurement%20of%20inflammatory%20markers.%20Cardiac%20structural%20and%20functional%20improvement%20was%20prospectively%20assessed%20via%20serial%20echocardiography.%20Eleven%20percent%20of%20the%20patients%20showed%20significant%20reverse%20remodeling%20following%20LVAD%20support%20%28ie%2C%20responders%29.%20Circulating%20tumor%20necrosis%20factor%20alpha%2C%20interleukin%20%28IL%29-4%2C%20IL-5%2C%20IL-6%2C%20IL-7%2C%20IL-13%2C%20and%20interferon%20gamma%20were%20lower%20in%20responders%2C%20compared%20with%20nonresponders%20%28P%26lt%3B0.05%2C%20all%20comparisons%29.%20The%20myocardial%20tissue%20signal%20transducer%20and%20activator%20of%20transcription-3%2C%20an%20inflammatory%20response%20regulator%2C%20was%20less%20activated%20in%20responders%20%28P%3D0.037%29.%20Guided%20by%20our%20tissue%20studies%20and%20a%20multivariable%20dichotomous%20regression%20analysis%2C%20we%20identified%20that%20low%20levels%20of%20circulating%20interferon%20gamma%20%28odds%20ratio%20%5BOR%5D%2C%200.06%3B%2095%25%20CI%2C%200.01-0.35%29%20and%20tumor%20necrosis%20factor%20alpha%20%28OR%2C%200.05%3B%2095%25%20CI%2C%200.00-0.43%29%2C%20independently%20predict%20cardiac%20improvement%2C%20creating%20a%202-cytokine%20model%20effectively%20predicting%20responders%20%28area%20under%20the%20curve%2C%200.903%3B%20P%26lt%3B0.0001%29.%20Conclusions%20Baseline%20myocardial%20and%20systemic%20inflammatory%20burden%20inversely%20correlates%20with%20cardiac%20improvement%20following%20LVAD%20support.%20A%20circulating%202-cytokine%20model%20predicting%20significant%20reverse%20remodeling%20was%20identified%2C%20warranting%20further%20investigation%20as%20a%20practical%20preintervention%20tool%20in%20identifying%20patients%20prone%20to%20LVAD-mediated%20cardiac%20improvement%20and%20device%20weaning.%22%2C%22date%22%3A%222021-10-19%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1161%5C%2FJAHA.120.020238%22%2C%22ISSN%22%3A%222047-9980%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2249D7YU3P%22%5D%2C%22dateModified%22%3A%222022-09-13T18%3A37%3A57Z%22%7D%7D%2C%7B%22key%22%3A%22NSPESXAY%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Slomovich%20et%20al.%22%2C%22parsedDate%22%3A%222021-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSlomovich%2C%20S.%2C%20Oh%2C%20K.%20T.%2C%20%26lt%3Bstrong%26gt%3BDiakos%26lt%3B%5C%2Fstrong%26gt%3B%2C%20N.%20A.%20et%20al.%20%282021%29.%20A%20Rare%20Case%20of%20Disseminated%20Tuberculosis%20and%20Hematological%20Malignancy%20in%20a%20Heart%20Transplant%20Recipient.%20%26lt%3Bi%26gt%3BTransplant%20Proc%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B53%26lt%3B%5C%2Fi%26gt%3B%2C%202626%26%23x2013%3B2629.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.transproceed.2021.07.037%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.transproceed.2021.07.037%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20Rare%20Case%20of%20Disseminated%20Tuberculosis%20and%20Hematological%20Malignancy%20in%20a%20Heart%20Transplant%20Recipient%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sharon%22%2C%22lastName%22%3A%22Slomovich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyung%20Taek%22%2C%22lastName%22%3A%22Oh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikolaos%20A.%22%2C%22lastName%22%3A%22Diakos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susan%20W.%22%2C%22lastName%22%3A%22Restaino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%20J.%22%2C%22lastName%22%3A%22Clerkin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Farhana%22%2C%22lastName%22%3A%22Latif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%20T.%22%2C%22lastName%22%3A%22Miyauchi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriel%20T.%22%2C%22lastName%22%3A%22Sayer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nir%22%2C%22lastName%22%3A%22Uriel%22%7D%5D%2C%22abstractNote%22%3A%22A%2077-year-old%20man%20who%20underwent%20a%20heart%20transplant%207%20years%20ago%20presented%20with%20multiple%20bloody%20bowel%20movements.%20Endoscopic%20and%20histologic%20evaluation%20revealed%20chronic%20active%20ileitis%2C%20granulomatous%20inflammation%2C%20multinucleated%20giant%20cells%2C%20and%20a%20rare%2C%20equivocal%20acid-fast%20bacterium%20in%20the%20terminal%20ileum.%20Positive%20sputum%20cultures%20for%20Mycobacterium%20tuberculosis%20and%20acid-fast%20bacilli%20established%20a%20diagnosis%20of%20intestinal%20tuberculosis%2C%20and%20RIPE%20%28rifabutin%2C%20isoniazid%2C%20pyrazinamide%2C%20ethambutol%29%20therapy%20was%20initiated.%20Elevated%20IgG%20levels%20on%20quantitative%20immunoglobulin%20testing%20and%20a%20bone%20marrow%20biopsy%20specimen%20of%20%5Cu226560%25%20plasma%20cells%20confirmed%20the%20diagnosis%20of%20multiple%20myeloma%20that%20later%20transformed%20into%20its%20aggressive%20form%2C%20plasma%20cell%20leukemia.%20Induction%20chemotherapy%20was%20initiated%3B%20however%2C%20the%20patient%20experienced%20retroperitoneal%20bleeding%20and%20pancytopenias%2C%20limiting%20the%20continuation%20of%20chemotherapy%2C%20and%20as%20a%20result%2C%20the%20patient%20was%20transitioned%20to%20palliative%20care.%22%2C%22date%22%3A%222021-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.transproceed.2021.07.037%22%2C%22ISSN%22%3A%221873-2623%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2249D7YU3P%22%5D%2C%22dateModified%22%3A%222022-09-13T18%3A37%3A57Z%22%7D%7D%2C%7B%22key%22%3A%22IVCQEM8C%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kampaktsis%20et%20al.%22%2C%22parsedDate%22%3A%222021-08%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKampaktsis%2C%20P.%20N.%2C%20Tzani%2C%20A.%2C%20Doulamis%2C%20I.%20P.%20et%20al.%20%282021%29.%20State-of-the-art%20machine%20learning%20algorithms%20for%20the%20prediction%20of%20outcomes%20after%20contemporary%20heart%20transplantation%3A%20Results%20from%20the%20UNOS%20database.%20%26lt%3Bi%26gt%3BClin%20Transplant%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B35%26lt%3B%5C%2Fi%26gt%3B%2C%20e14388.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fctr.14388%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fctr.14388%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22State-of-the-art%20machine%20learning%20algorithms%20for%20the%20prediction%20of%20outcomes%20after%20contemporary%20heart%20transplantation%3A%20Results%20from%20the%20UNOS%20database%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Polydoros%20N.%22%2C%22lastName%22%3A%22Kampaktsis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aspasia%22%2C%22lastName%22%3A%22Tzani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ilias%20P.%22%2C%22lastName%22%3A%22Doulamis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Serafeim%22%2C%22lastName%22%3A%22Moustakidis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anastasios%22%2C%22lastName%22%3A%22Drosou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikolaos%22%2C%22lastName%22%3A%22Diakos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stavros%20G.%22%2C%22lastName%22%3A%22Drakos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandros%22%2C%22lastName%22%3A%22Briasoulis%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20We%20sought%20to%20develop%20and%20validate%20machine%20learning%20%28ML%29%20models%20to%20increase%20the%20predictive%20accuracy%20of%20mortality%20after%20heart%20transplantation%20%28HT%29.%5CnMETHODS%20AND%20RESULTS%3A%20We%20included%20adult%20HT%20recipients%20from%20the%20United%20Network%20for%20Organ%20Sharing%20%28UNOS%29%20database%20between%202010%20and%202018%20using%20solely%20pre-transplant%20variables.%20The%20study%20cohort%20comprised%2018%5Cu00a0625%20patients%20%2853%20%5Cu00b1%2013%5Cu00a0years%2C%2073%25%20males%29%20and%20was%20randomly%20split%20into%20a%20derivation%20and%20a%20validation%20cohort%20with%20a%203%3A1%20ratio.%20At%201-year%20after%20HT%2C%20there%20were%202334%20%2812.5%25%29%20deaths.%20Out%20of%20a%20total%20of%20134%20pre-transplant%20variables%2C%2039%20were%20selected%20as%20highly%20predictive%20of%201-year%20mortality%20via%20feature%20selection%20algorithm%20and%20were%20used%20to%20train%20five%20ML%20models.%20AUC%20for%20the%20prediction%20of%201-year%20survival%20was%20.689%2C%20.642%2C%20.649%2C%20.637%2C%20.526%20for%20the%20Adaboost%2C%20Logistic%20Regression%2C%20Decision%20Tree%2C%20Support%20Vector%20Machine%2C%20and%20K-nearest%20neighbor%20models%2C%20respectively%2C%20whereas%20the%20Index%20for%20Mortality%20Prediction%20after%20Cardiac%20Transplantation%20%28IMPACT%29%20score%20had%20an%20AUC%20of%20.569.%20Local%20interpretable%20model-agnostic%20explanations%20%28LIME%29%20analysis%20was%20used%20in%20the%20best%20performing%20model%20to%20identify%20the%20relative%20impact%20of%20key%20predictors.%20ML%20models%20for%203-%20and%205-year%20survival%20as%20well%20as%20acute%20rejection%20were%20also%20developed%20in%20a%20secondary%20analysis%20and%20yielded%20AUCs%20of%20.629%2C%20.609%2C%20and%20.610%20using%2027%2C%2031%2C%20and%2091%20selected%20variables%20respectively.%5CnCONCLUSION%3A%20Machine%20learning%20models%20showed%20good%20predictive%20accuracy%20of%20outcomes%20after%20heart%20transplantation.%22%2C%22date%22%3A%222021-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Fctr.14388%22%2C%22ISSN%22%3A%221399-0012%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2249D7YU3P%22%5D%2C%22dateModified%22%3A%222022-09-13T18%3A37%3A57Z%22%7D%7D%2C%7B%22key%22%3A%22CFVQKCFG%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Diakos%20et%20al.%22%2C%22parsedDate%22%3A%222021-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BDiakos%26lt%3B%5C%2Fstrong%26gt%3B%2C%20N.%20A.%2C%20Thayer%2C%20K.%2C%20Swain%2C%20L.%20et%20al.%20%282021%29.%20Systemic%20Inflammatory%20Burden%20Correlates%20with%20Severity%20and%20Predicts%20Outcomes%20in%20Patients%20with%20Cardiogenic%20Shock%20Supported%20by%20a%20Percutaneous%20Mechanical%20Assist%20Device.%20%26lt%3Bi%26gt%3BJ%20Cardiovasc%20Transl%20Res%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B14%26lt%3B%5C%2Fi%26gt%3B%2C%20476%26%23x2013%3B483.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs12265-020-10078-5%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs12265-020-10078-5%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Systemic%20Inflammatory%20Burden%20Correlates%20with%20Severity%20and%20Predicts%20Outcomes%20in%20Patients%20with%20Cardiogenic%20Shock%20Supported%20by%20a%20Percutaneous%20Mechanical%20Assist%20Device%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikolaos%20A.%22%2C%22lastName%22%3A%22Diakos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%22%2C%22lastName%22%3A%22Thayer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lija%22%2C%22lastName%22%3A%22Swain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maithri%22%2C%22lastName%22%3A%22Goud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pankaj%22%2C%22lastName%22%3A%22Jain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Navin%20K.%22%2C%22lastName%22%3A%22Kapur%22%7D%5D%2C%22abstractNote%22%3A%22In-hospital%20mortality%20associated%20with%20cardiogenic%20shock%20%28CS%29%20remains%20high%20despite%20introduction%20of%20mechanical%20circulatory%20support.%20In%20this%20study%2C%20we%20aimed%20to%20investigate%20whether%20systemic%20inflammation%20is%20associated%20with%20clinical%20outcomes%20in%20CS.%20We%20retrospectively%20analyzed%20systemic%20cytokine%20levels%20and%20the%20neutrophil-to-lymphocyte%20ratio%20%28NLR%29%2C%20a%20marker%20of%20low-grade%20inflammation%2C%20among%20134%20patients%20with%20CS%20supported%20by%20VA-ECMO%20or%20Impella.%20Sixty-one%20percent%20of%20patients%20survived%20CS%20and%20either%20underwent%20device%20explantation%20or%20were%20bridged%20to%20LVAD%20or%20cardiac%20transplant.%20IL6%20was%20the%20predominant%20circulating%20cytokine.%20IL6%20levels%20were%20reduced%20after%20circulatory%20support%20in%20survivors.%20NLR%20pre-device%20implantation%20was%20significantly%20lower%20in%20patients%20with%20earlier%20stages%20of%20cardiogenic%20shock.%20Compared%20with%20non-survivors%2C%20survivors%20had%20a%20lower%20pre-device%20NLR%20and%20NLR%20was%20independently%20predictive%20of%20survival%20after%20adjusting%20for%20other%20covariates.%20In%20summary%2C%20NLR%20is%20a%20widely%20available%20marker%20of%20inflammation%20and%20correlates%20with%20in-hospital%20mortality%20among%20patients%20with%20cardiogenic%20shock%20requiring%20percutaneous%20mechanical%20circulatory%20support.%20Graphical%20Abstract%20Survivors%20present%20with%20lower%20NLR%20levels%20prior%20to%20percutaneous%20device%20implantation.%20Both%20survivors%20and%20non%20survivors%20present%20with%20elevated%20IL6%20levels.%20IL6%20levels%20decrease%20after%20percutaneous%20support%20%28ECMO%20or%20Impella%29%20only%20in%20survivors%20and%20continue%20to%20rise%20in%20non-survivors.%22%2C%22date%22%3A%222021-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs12265-020-10078-5%22%2C%22ISSN%22%3A%221937-5395%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2249D7YU3P%22%5D%2C%22dateModified%22%3A%222022-09-13T18%3A37%3A57Z%22%7D%7D%2C%7B%22key%22%3A%22BZU2XFWG%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cluntun%20et%20al.%22%2C%22parsedDate%22%3A%222021-03-02%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCluntun%2C%20A.%20A.%2C%20Badolia%2C%20R.%2C%20Lettlova%2C%20S.%20et%20al.%20%282021%29.%20The%20pyruvate-lactate%20axis%20modulates%20cardiac%20hypertrophy%20and%20heart%20failure.%20%26lt%3Bi%26gt%3BCell%20Metab%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B33%26lt%3B%5C%2Fi%26gt%3B%2C%20629-648.e10.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmet.2020.12.003%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmet.2020.12.003%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20pyruvate-lactate%20axis%20modulates%20cardiac%20hypertrophy%20and%20heart%20failure%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahmad%20A.%22%2C%22lastName%22%3A%22Cluntun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachit%22%2C%22lastName%22%3A%22Badolia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%22%2C%22lastName%22%3A%22Lettlova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20Mark%22%2C%22lastName%22%3A%22Parnell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thirupura%20S.%22%2C%22lastName%22%3A%22Shankar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikolaos%20A.%22%2C%22lastName%22%3A%22Diakos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristofor%20A.%22%2C%22lastName%22%3A%22Olson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Iosif%22%2C%22lastName%22%3A%22Taleb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sean%20M.%22%2C%22lastName%22%3A%22Tatum%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jordan%20A.%22%2C%22lastName%22%3A%22Berg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corey%20N.%22%2C%22lastName%22%3A%22Cunningham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tyler%22%2C%22lastName%22%3A%22Van%20Ry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alex%20J.%22%2C%22lastName%22%3A%22Bott%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aspasia%20Thodou%22%2C%22lastName%22%3A%22Krokidi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Fogarty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophia%22%2C%22lastName%22%3A%22Skedros%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wojciech%20I.%22%2C%22lastName%22%3A%22Swiatek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xuejing%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bai%22%2C%22lastName%22%3A%22Luo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Merx%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sutip%22%2C%22lastName%22%3A%22Navankasattusas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20E.%22%2C%22lastName%22%3A%22Cox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20S.%22%2C%22lastName%22%3A%22Ducker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20L.%22%2C%22lastName%22%3A%22Holland%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20H.%22%2C%22lastName%22%3A%22McKellar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jared%22%2C%22lastName%22%3A%22Rutter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stavros%20G.%22%2C%22lastName%22%3A%22Drakos%22%7D%5D%2C%22abstractNote%22%3A%22The%20metabolic%20rewiring%20of%20cardiomyocytes%20is%20a%20widely%20accepted%20hallmark%20of%20heart%20failure%20%28HF%29.%20These%20metabolic%20changes%20include%20a%20decrease%20in%20mitochondrial%20pyruvate%20oxidation%20and%20an%20increased%20export%20of%20lactate.%20We%20identify%20the%20mitochondrial%20pyruvate%20carrier%20%28MPC%29%20and%20the%20cellular%20lactate%20exporter%20monocarboxylate%20transporter%204%20%28MCT4%29%20as%20pivotal%20nodes%20in%20this%20metabolic%20axis.%20We%20observed%20that%20cardiac%20assist%20device-induced%20myocardial%20recovery%20in%20chronic%20HF%20patients%20was%20coincident%20with%20increased%20myocardial%20expression%20of%20the%20MPC.%20Moreover%2C%20the%20genetic%20ablation%20of%20the%20MPC%20in%20cultured%20cardiomyocytes%20and%20in%20adult%20murine%20hearts%20was%20sufficient%20to%20induce%20hypertrophy%20and%20HF.%20Conversely%2C%20MPC%20overexpression%20attenuated%20drug-induced%20hypertrophy%20in%20a%20cell-autonomous%20manner.%20We%20also%20introduced%20a%20novel%2C%20highly%20potent%20MCT4%20inhibitor%20that%20mitigated%20hypertrophy%20in%20cultured%20cardiomyocytes%20and%20in%20mice.%20Together%2C%20we%20find%20that%20alteration%20of%20the%20pyruvate-lactate%20axis%20is%20a%20fundamental%20and%20early%20feature%20of%20cardiac%20hypertrophy%20and%20failure.%22%2C%22date%22%3A%222021-03-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cmet.2020.12.003%22%2C%22ISSN%22%3A%221932-7420%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2249D7YU3P%22%5D%2C%22dateModified%22%3A%222022-09-13T18%3A37%3A57Z%22%7D%7D%2C%7B%22key%22%3A%229C6GPCB3%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Larson%20et%20al.%22%2C%22parsedDate%22%3A%222021-03-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLarson%2C%20A.%2C%20Libermann%2C%20T.%20A.%2C%20Bowditch%2C%20H.%20et%20al.%20%282021%29.%20Plasma%20Proteomic%20Profiling%20in%20Hypertrophic%20Cardiomyopathy%20Patients%20before%20and%20after%20Surgical%20Myectomy%20Reveals%20Post-Procedural%20Reduction%20in%20Systemic%20Inflammation.%20%26lt%3Bi%26gt%3BInt%20J%20Mol%20Sci%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B22%26lt%3B%5C%2Fi%26gt%3B%2C%202474.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fijms22052474%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fijms22052474%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Plasma%20Proteomic%20Profiling%20in%20Hypertrophic%20Cardiomyopathy%20Patients%20before%20and%20after%20Surgical%20Myectomy%20Reveals%20Post-Procedural%20Reduction%20in%20Systemic%20Inflammation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%22%2C%22lastName%22%3A%22Larson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Towia%20A.%22%2C%22lastName%22%3A%22Libermann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heather%22%2C%22lastName%22%3A%22Bowditch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gaurav%22%2C%22lastName%22%3A%22Das%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikolaos%22%2C%22lastName%22%3A%22Diakos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gordon%20S.%22%2C%22lastName%22%3A%22Huggins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hassan%22%2C%22lastName%22%3A%22Rastegar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frederick%20Y.%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ethan%20J.%22%2C%22lastName%22%3A%22Rowin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%20S.%22%2C%22lastName%22%3A%22Maron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20T.%22%2C%22lastName%22%3A%22Chin%22%7D%5D%2C%22abstractNote%22%3A%22Left%20Ventricular%20Outflow%20Tract%20%28LVOT%29%20obstruction%20occurs%20in%20approximately%2070%25%20of%20Hypertrophic%20Cardiomyopathy%20%28HCM%29%20patients%20and%20currently%20requires%20imaging%20or%20invasive%20testing%20for%20diagnosis%2C%20sometimes%20in%20conjunction%20with%20provocative%20physiological%20or%20pharmaceutical%20stimuli.%20To%20identify%20potential%20biomarkers%20of%20LVOT%20obstruction%2C%20we%20performed%20proteomics%20profiling%20of%201305%20plasma%20proteins%20in%2012%20HCM%20patients%20with%20documented%20LVOT%20obstruction%2C%20referred%20for%20surgical%20myectomy.%20Plasma%20was%20collected%20at%20the%20surgical%20preoperative%20visit%2C%20approximately%20one%20month%20prior%20to%20surgery%20and%20then%20at%20the%20post-surgical%20visit%2C%20approximately%203%20months%20later.%20Proteomic%20profiles%20were%20generated%20using%20the%20aptamer-based%20SOMAscan%20assay.%20Principal%20Component%20Analysis%20using%20the%20highest%20statistically%20significant%20proteins%20separated%20all%20preoperative%20samples%20from%20all%20postoperative%20samples.%20Further%20analysis%20revealed%20a%20set%20of%2025%20proteins%20that%20distinguished%20the%20preoperative%20and%20postoperative%20states%20with%20a%20paired%20t-test%20p-value%20of%20%26lt%3B0.01.%20Ingenuity%20Pathway%20analysis%20facilitated%20the%20generation%20of%20protein%20interaction%20networks%20and%20the%20elucidation%20of%20key%20upstream%20regulators%20of%20differentially%20expressed%20proteins%2C%20such%20as%20interferon-%5Cu03b3%2C%20TGF-%5Cu03b21%2C%20and%20TNF.%20Biological%20pathways%20affected%20by%20surgery%20included%20organ%20inflammation%2C%20migration%2C%20and%20motility%20of%20leukocytes%2C%20fibrosis%2C%20vasculogenesis%2C%20angiogenesis%2C%20acute%20coronary%20events%2C%20endothelial%20proliferation%2C%20eicosanoid%20metabolism%2C%20calcium%20flux%2C%20apoptosis%2C%20and%20morphology%20of%20the%20cardiovascular%20system.%20Our%20results%20indicate%20that%20surgical%20relief%20of%20dynamic%20outflow%20tract%20obstruction%20in%20HCM%20patients%20is%20associated%20with%20unique%20alterations%20in%20plasma%20proteomic%20profiles%20that%20likely%20reflect%20improvement%20in%20organ%20inflammation%20and%20physiological%20function.%22%2C%22date%22%3A%222021-03-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3390%5C%2Fijms22052474%22%2C%22ISSN%22%3A%221422-0067%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2249D7YU3P%22%5D%2C%22dateModified%22%3A%222022-09-13T18%3A38%3A24Z%22%7D%7D%2C%7B%22key%22%3A%22PHLTZSKJ%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Koliopoulou%20et%20al.%22%2C%22parsedDate%22%3A%222020-12%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKoliopoulou%2C%20A.%20G.%2C%20Bonios%2C%20M.%20J.%2C%20%26lt%3Bstrong%26gt%3BDiakos%26lt%3B%5C%2Fstrong%26gt%3B%2C%20N.%20A.%20et%20al.%20%282020%29.%20Biventricular%20failure%20and%20total%20artificial%20heart%3A%20Old%20and%20new%20solutions%20for%20a%20vexing%20problem.%20%26lt%3Bi%26gt%3BHellenic%20J%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B61%26lt%3B%5C%2Fi%26gt%3B%2C%20413%26%23x2013%3B414.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.hjc.2021.02.010%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.hjc.2021.02.010%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Biventricular%20failure%20and%20total%20artificial%20heart%3A%20Old%20and%20new%20solutions%20for%20a%20vexing%20problem%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antigone%20G.%22%2C%22lastName%22%3A%22Koliopoulou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20J.%22%2C%22lastName%22%3A%22Bonios%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikolaos%20A.%22%2C%22lastName%22%3A%22Diakos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stavros%20G.%22%2C%22lastName%22%3A%22Drakos%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222020%20Nov-Dec%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.hjc.2021.02.010%22%2C%22ISSN%22%3A%222241-5955%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2249D7YU3P%22%5D%2C%22dateModified%22%3A%222022-09-13T18%3A37%3A57Z%22%7D%7D%2C%7B%22key%22%3A%22RXKQ8YIP%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Riehle%20et%20al.%22%2C%22parsedDate%22%3A%222020-03-26%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BRiehle%2C%20C.%2C%20Weatherford%2C%20E.%20T.%2C%20Wende%2C%20A.%20R.%20et%20al.%20%282020%29.%20Insulin%20receptor%20substrates%20differentially%20exacerbate%20insulin-mediated%20left%20ventricular%20remodeling.%20%26lt%3Bi%26gt%3BJCI%20Insight%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B5%26lt%3B%5C%2Fi%26gt%3B%2C%20134920.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1172%5C%2Fjci.insight.134920%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1172%5C%2Fjci.insight.134920%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Insulin%20receptor%20substrates%20differentially%20exacerbate%20insulin-mediated%20left%20ventricular%20remodeling%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Riehle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20T.%22%2C%22lastName%22%3A%22Weatherford%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20R.%22%2C%22lastName%22%3A%22Wende%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bharat%20P.%22%2C%22lastName%22%3A%22Jaishy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alec%20W.%22%2C%22lastName%22%3A%22Seei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%20S.%22%2C%22lastName%22%3A%22McCarty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Monika%22%2C%22lastName%22%3A%22Rech%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qian%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gopireddy%20R.%22%2C%22lastName%22%3A%22Reddy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20J.%22%2C%22lastName%22%3A%22Kutschke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Oliveira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karla%20Maria%22%2C%22lastName%22%3A%22Pires%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20C.%22%2C%22lastName%22%3A%22Anderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikolaos%20A.%22%2C%22lastName%22%3A%22Diakos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20M.%22%2C%22lastName%22%3A%22Weiss%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Morris%20F.%22%2C%22lastName%22%3A%22White%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stavros%20G.%22%2C%22lastName%22%3A%22Drakos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yang%20K.%22%2C%22lastName%22%3A%22Xiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20Dale%22%2C%22lastName%22%3A%22Abel%22%7D%5D%2C%22abstractNote%22%3A%22Pressure%20overload%20%28PO%29%20cardiac%20hypertrophy%20and%20heart%20failure%20are%20associated%20with%20generalized%20insulin%20resistance%20and%20hyperinsulinemia%2C%20which%20may%20exacerbate%20left%20ventricular%20%28LV%29%20remodeling.%20While%20PO%20activates%20insulin%20receptor%20tyrosine%20kinase%20activity%20that%20is%20transduced%20by%20insulin%20receptor%20substrate%201%20%28IRS1%29%2C%20the%20present%20study%20tested%20the%20hypothesis%20that%20IRS1%20and%20IRS2%20have%20divergent%20effects%20on%20PO-induced%20LV%20remodeling.%20We%20therefore%20subjected%20mice%20with%20cardiomyocyte-restricted%20deficiency%20of%20IRS1%20%28CIRS1KO%29%20or%20IRS2%20%28CIRS2KO%29%20to%20PO%20induced%20by%20transverse%20aortic%20constriction%20%28TAC%29.%20In%20WT%20mice%2C%20TAC-induced%20LV%20hypertrophy%20was%20associated%20with%20hyperactivation%20of%20IRS1%20and%20Akt1%2C%20but%20not%20IRS2%20and%20Akt2.%20CIRS1KO%20hearts%20were%20resistant%20to%20cardiac%20hypertrophy%20and%20heart%20failure%20in%20concert%20with%20attenuated%20Akt1%20activation.%20In%20contrast%2C%20CIRS2KO%20hearts%20following%20TAC%20developed%20more%20severe%20LV%20dysfunction%20than%20WT%20controls%2C%20and%20this%20was%20prevented%20by%20haploinsufficiency%20of%20Akt1.%20Failing%20human%20hearts%20exhibited%20isoform-specific%20IRS1%20and%20Akt1%20activation%2C%20while%20IRS2%20and%20Akt2%20activation%20were%20unchanged.%20Kinomic%20profiling%20identified%20IRS1%20as%20a%20potential%20regulator%20of%20cardioprotective%20protein%20kinase%20G-mediated%20signaling.%20In%20addition%2C%20gene%20expression%20profiling%20revealed%20that%20IRS1%20signaling%20may%20promote%20a%20proinflammatory%20response%20following%20PO.%20Together%2C%20these%20data%20identify%20IRS1%20and%20Akt1%20as%20critical%20signaling%20nodes%20that%20mediate%20LV%20remodeling%20in%20both%20mice%20and%20humans.%22%2C%22date%22%3A%222020-03-26%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1172%5C%2Fjci.insight.134920%22%2C%22ISSN%22%3A%222379-3708%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2249D7YU3P%22%5D%2C%22dateModified%22%3A%222022-09-13T18%3A37%3A57Z%22%7D%7D%2C%7B%22key%22%3A%22L9IEJYYZ%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Symons%20et%20al.%22%2C%22parsedDate%22%3A%222019-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSymons%2C%20J.%20D.%2C%20Deeter%2C%20L.%2C%20Deeter%2C%20N.%20et%20al.%20%282019%29.%20Effect%20of%20Continuous-Flow%20Left%20Ventricular%20Assist%20Device%20Support%20on%20Coronary%20Artery%20Endothelial%20Function%20in%20Ischemic%20and%20Nonischemic%20Cardiomyopathy.%20%26lt%3Bi%26gt%3BCirc%20Heart%20Fail%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B12%26lt%3B%5C%2Fi%26gt%3B%2C%20e006085.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FCIRCHEARTFAILURE.119.006085%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FCIRCHEARTFAILURE.119.006085%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Effect%20of%20Continuous-Flow%20Left%20Ventricular%20Assist%20Device%20Support%20on%20Coronary%20Artery%20Endothelial%20Function%20in%20Ischemic%20and%20Nonischemic%20Cardiomyopathy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20David%22%2C%22lastName%22%3A%22Symons%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lance%22%2C%22lastName%22%3A%22Deeter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%22%2C%22lastName%22%3A%22Deeter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Trevor%22%2C%22lastName%22%3A%22Bonn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jae%20Min%22%2C%22lastName%22%3A%22Cho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Ferrin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lauren%22%2C%22lastName%22%3A%22McCreath%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikolaos%20A.%22%2C%22lastName%22%3A%22Diakos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Iosif%22%2C%22lastName%22%3A%22Taleb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rami%22%2C%22lastName%22%3A%22Alharethi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%22%2C%22lastName%22%3A%22McKellar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Wever-Pinzon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sutip%22%2C%22lastName%22%3A%22Navankasattusas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Craig%20H.%22%2C%22lastName%22%3A%22Selzman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20C.%22%2C%22lastName%22%3A%22Fang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stavros%20G.%22%2C%22lastName%22%3A%22Drakos%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20coronary%20vasculature%20encounters%20a%20reduction%20in%20pulsatility%20after%20implementing%20durable%20continuous-flow%20left%20ventricular%20assist%20device%20%28CF-LVAD%29%20circulatory%20support.%20Evidence%20exists%20that%20appropriate%20pulsatility%20is%20required%20to%20maintain%20endothelial%20cell%20homeostasis.%20We%20hypothesized%20that%20coronary%20artery%20endothelial%20function%20would%20be%20impaired%20after%20CF-LVAD%20intervention.%5CnMETHODS%20AND%20RESULTS%3A%20Coronary%20arteries%20from%20patients%20with%20end-stage%20heart%20failure%20caused%20by%20ischemic%20cardiomyopathy%20%28ICM%3B%20n%3D16%29%20or%20non-ICM%20%28n%3D22%29%20cardiomyopathy%20were%20isolated%20from%20the%20left%20ventricular%20apical%20core%2C%20which%20was%20removed%20for%20the%20CF-LVAD%20implantation.%20In%2011%20of%20these%20patients%2C%20paired%20coronary%20arteries%20were%20obtained%20from%20an%20adjacent%20region%20of%20myocardium%20after%20the%20CF-LVAD%20intervention%20%28n%3D6%20ICM%2C%205%20non-ICM%29.%20Vascular%20function%20was%20assessed%20ex%20vivo%20using%20isometric%20tension%20procedures%20in%20these%20patients%20and%20in%207%20nonfailing%20donor%20controls.%20Maximal%20endothelium-dependent%20vasorelaxation%20to%20BK%20%28bradykinin%3B%2010-6-10-10%20M%29%20was%20blunted%20%28P%26lt%3B0.05%29%20in%20arteries%20from%20patients%20with%20ICM%20compared%20with%20non-ICM%20and%20donor%20controls%2C%20whereas%20responses%20to%20sodium%20nitroprusside%20%2810-4-10-9%20M%29%20were%20similar%20among%20the%20groups.%20Contrary%20to%20our%20hypothesis%2C%20vasorelaxation%20responses%20to%20BK%20and%20sodium%20nitroprusside%20were%20similar%20before%20and%20219%5Cu00b137%20days%20after%20CF-LVAD%20support.%20Of%20these%20patients%2C%20an%20exploratory%20subgroup%20analysis%20revealed%20that%20BK-induced%20coronary%20artery%20vasorelaxation%20was%20greater%20%28P%26lt%3B0.05%29%20after%20%2887%5Cu00b16%25%29%20versus%20before%20%2854%5Cu00b114%25%29%20CF-LVAD%20intervention%20in%20ICM%20patients%2C%20whereas%20sodium%20nitroprusside-evoked%20responses%20were%20similar.%5CnCONCLUSIONS%3A%20Coronary%20artery%20endothelial%20function%20is%20not%20impaired%20by%20durable%20CF-LVAD%20support%20and%20in%20ICM%20patients%20appears%20to%20be%20improved.%20Investigating%20coronary%20endothelial%20function%20using%20in%20vivo%20approaches%20in%20a%20larger%20patient%20population%20is%20warranted.%22%2C%22date%22%3A%222019-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1161%5C%2FCIRCHEARTFAILURE.119.006085%22%2C%22ISSN%22%3A%221941-3297%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2249D7YU3P%22%5D%2C%22dateModified%22%3A%222022-09-13T18%3A38%3A24Z%22%7D%7D%5D%7D
Diakos, N. A. (2023). Management of cardiogenic shock: Present and future. Tex Heart Inst J 50, e238119. https://doi.org/10.14503/THIJ-23-8119.
Diakos, N. A., Taleb, I., Kyriakopoulos, C. P. et al. (2021). Circulating and Myocardial Cytokines Predict Cardiac Structural and Functional Improvement in Patients With Heart Failure Undergoing Mechanical Circulatory Support. J Am Heart Assoc 10, e020238. https://doi.org/10.1161/JAHA.120.020238.
Slomovich, S., Oh, K. T., Diakos, N. A. et al. (2021). A Rare Case of Disseminated Tuberculosis and Hematological Malignancy in a Heart Transplant Recipient. Transplant Proc 53, 2626–2629. https://doi.org/10.1016/j.transproceed.2021.07.037.
Kampaktsis, P. N., Tzani, A., Doulamis, I. P. et al. (2021). State-of-the-art machine learning algorithms for the prediction of outcomes after contemporary heart transplantation: Results from the UNOS database. Clin Transplant 35, e14388. https://doi.org/10.1111/ctr.14388.
Diakos, N. A., Thayer, K., Swain, L. et al. (2021). Systemic Inflammatory Burden Correlates with Severity and Predicts Outcomes in Patients with Cardiogenic Shock Supported by a Percutaneous Mechanical Assist Device. J Cardiovasc Transl Res 14, 476–483. https://doi.org/10.1007/s12265-020-10078-5.
Cluntun, A. A., Badolia, R., Lettlova, S. et al. (2021). The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure. Cell Metab 33, 629-648.e10. https://doi.org/10.1016/j.cmet.2020.12.003.
Larson, A., Libermann, T. A., Bowditch, H. et al. (2021). Plasma Proteomic Profiling in Hypertrophic Cardiomyopathy Patients before and after Surgical Myectomy Reveals Post-Procedural Reduction in Systemic Inflammation. Int J Mol Sci 22, 2474. https://doi.org/10.3390/ijms22052474.
Koliopoulou, A. G., Bonios, M. J., Diakos, N. A. et al. (2020). Biventricular failure and total artificial heart: Old and new solutions for a vexing problem. Hellenic J Cardiol 61, 413–414. https://doi.org/10.1016/j.hjc.2021.02.010.
Riehle, C., Weatherford, E. T., Wende, A. R. et al. (2020). Insulin receptor substrates differentially exacerbate insulin-mediated left ventricular remodeling. JCI Insight 5, 134920. https://doi.org/10.1172/jci.insight.134920.
Symons, J. D., Deeter, L., Deeter, N. et al. (2019). Effect of Continuous-Flow Left Ventricular Assist Device Support on Coronary Artery Endothelial Function in Ischemic and Nonischemic Cardiomyopathy. Circ Heart Fail 12, e006085. https://doi.org/10.1161/CIRCHEARTFAILURE.119.006085.

The Texas Heart Institute® at Baylor College of Medicine 2025

Privacy Policy & Terms of Use

Bringing the future of cardiovascular health to life.®